Lori M.B. Laffel
Joslin Diabetes Center
230 Papers
1.3K Citations
Lori M.B. Laffel is an academic researcher from Joslin Diabetes Center. The author has contributed to research in topics: Medicine & Diabetes mellitus. The author has an hindex of 67, co-authored 146 publications. Previous affiliations of Lori M.B. Laffel include Children's Memorial Hospital & Cincinnati Children's Hospital Medical Center.
Chat about Author
Papers
Development and delivery of a brief family behavioral intervention to support continuous glucose monitor use in young children with type 1 diabetes
Marisa E. Hilliard,Persis V. Commissariat,Lauren Kanapka,Lori M.B. Laffel,Wendy Levy,Kara R. Harrington,Barbara J. Anderson,Kellee M. Miller,Linda A. DiMeglio +8 more
TL;DR: A 5‐session family behavioral intervention (FBI) to support CGM use in young children with type 1 diabetes and its potential glycemic benefits are investigated.
6
Assessing Incorporation of Type 1 Diabetes Into Identity: Validation of the Accepting Diabetes And Personal Treatment Survey in Teens and Young Adults.
TL;DR: The Accepting Diabetes and Personal Treatment (ADAPT) survey as mentioned in this paper was designed for adolescents and young adults with Type 1 diabetes (T1D) and validated measures of fear of hypoglycemia, diabetes distress and quality of life.
6
Comparison of longitudinal point-of-care and high-performance liquid chromatography HbA1c measurements in a multi-centre trial.
C. R. Alleyn,Lori M.B. Laffel,Lisa K. Volkening,Barbara J. Anderson,Tonja R. Nansel,T. Wysocki,Jill Weissberg-Benchell +6 more
TL;DR: In this article, a comparison of point-of-care HbA1c against laboratory measurements across sites and over time is warranted, by measuring the change in Hb1c over time by difference from initial to final HbAs and by growth modelling with annualized slope calculation.
6
Renin Release in Response to Renin System Blockade: Activation of the Renin System in Type 1 Diabetes Mellitus
Radomir Stevanovic,Deborah A. Price,M. Cecilia Lansang,Naomi D.L. Fisher,Lori M.B. Laffel,Norman K. Hollenberg +5 more
TL;DR: Renin response to ACE-I and ARB confirms activation of the RAS in diabetic patients and increases PRA, as anticipated.
6
•Journal Article
Challenges and opportunities in diabetes care: improving outcomes with education, disease management, and new technologies.
TL;DR: Point-of-care testing of beta-hydroxybutyrate concentrations, whether in the home or the physician's office, augments blood glucose monitoring and serves as an important tool for the routine management of diabetes.
5